- Home
- »
- Biotechnology
- »
-
Biobanks Market Size, Share & Trends, Industry Report, 2030GVR Report cover
![Biobanks Market Size, Share & Trends Report]()
Biobanks Market Size, Share & Trends Analysis Report By Product & Services (LIMS, Biobanking Equipment), By Biospecimen Type (Organs, Stem Cells), By Biobanks Type (Real, Virtual), By Application, By Region, And Segment Forecasts, 2025 - 2030
- Report ID: GVR-2-68038-564-9
- Number of Report Pages: 185
- Format: PDF
- Historical Range: 2018 - 2024
- Forecast Period: 2025 - 2030
- Industry: Healthcare
Biobanks Market Size & Trends
The global biobanks market size was estimated at USD 81.29 billion in 2024 and is expected to grow at a CAGR of 7.85% from 2025 to 2030. High investments in the R&D of advanced therapies, such as regenerative medicine, personalized medicine, and cancer genomic studies, are some of the driving factors.
Key Highlights:
- Europe biobanks industry accounted for the largest revenue share of 39.37% in 2024
- The UK biobanks market growth is significantly driven by national-scale programs such as the UK Biobank project
- In terms of segment, the services segment dominated the market and accounted for the largest revenue share in 2024
- Based on biospecimen type, the global biobanks market has been categorized into human tissues, organs, stem cells, and other biospecimen
- Based on biobanks type, the global market is bifurcated into physical/real biobanks and virtual biobanks
- Based on application, the biobanks industry is categorized into therapeutics, drug discovery & clinical research, clinical diagnostics, and other applications
Moreover, the onset of COVID-19 has put biobanks at the forefront of the pandemic control measures, resulting in the organic revenue growth of the market. The COVID-19 outbreak had a major influence on the biobanks industry. Biobanking is important for the diagnosis & production of medicines for a variety of disorders. International initiatives to produce vaccines and other medicines to prevent the spread of the virus have been urgently needed.
The collection, processing, and analysis of patient samples are at the frontline of the COVID-19 crisis. For example, the Health Minister announced EUR 2 million in financing for the National Irish COVID-19 Biobank (NICB) in a July 2021 update from the Government of Ireland. The NICB has become a critical part of Ireland’s COVID-19 pandemic response. According to a February 2021 release, the Sample Collection Database was designed by the SciLifeLab Data Centre in partnership with Biobank Sweden and the research area ‘Biobanks for COVID-19’ of the SciLifeLab & KAW National COVID-19 research program. Furthermore, Tulane University announced a new COVID-19 biobank containing blood & cell samples from survivors in July 2021 to aid researchers in determining why some people heal rapidly while others have long-term effects. As a result, such activities show that the outbreak of the pandemic boosted the demand for biobank services, benefiting the global economy.
The increasing popularity of precision/personalized medicine and genetic testing has been a key driver of the market. Biobanks have been playing a significant role in biomedical research. Over the past few decades, there have been several advances in platforms and tools used in genetic studies. This has led to an increase in demand for biospecimens from clinical labs to develop assays for genetic testing. Collaborations between private and public institutions in biobanking have played a crucial role in market progression.
Digitalization, precision medicine, and virtualization are rapidly changing the biobanking industry through the development of novel methods and concepts of collaborations initiated by public and private organizations. Companies across all fields are partnering with biobanks, which accelerates the market revenue. For instance, in October 2023, UK Biobank partnered with several philanthropists. Through this partnership, UK Biobank will access USD 34.5 million in funding.
An exponential increase in the number of global cases has rendered the significance of biobanks in containing the spread of the virus. High-quality COVID-19 specimens are required and helpful for both research and diagnostic purposes, and biobanks are considered vital repositories for these samples. Thus, biobanks are gaining ground to support clinical research and drug discovery processes to combat this global disaster.
Furthermore, developing countries from the Middle East region are investing in biobanks to advance the medical research domain in the region. For instance, in September 2023, the Crown Prince of Abu Dhabi announced the launch of a biobank to support the requirement of personalized medicine through advanced treatments that utilize human tissues and stem cells in medical research. This research will help treat over 80 diseases and immune system issues. Moreover, it strengthens the position of the UAE in the global biobank market.
Biobanks play a critical role in advancing biomedical research by systematically collecting, storing, and managing biological specimens and associated data. These repositories support a wide range of applications, including drug discovery, genomics, personalized medicine, and public health studies. Below is a list of some of the largest and most influential biobanks operating globally, recognized for their scale, diversity of samples, and research impact.
List of largest biobanks across the globe:
Name
Size
Sample Type
Biobank Graz
20 million
Serum, EDTA-plasma, buffy coat, urine, whole blood, Na-citrate plasma, fresh frozen tissue, FFPE tissue, PAXgene blood, cerebrospinal fluid, stool, throat swabs, placenta, umbilical cord blood, mononuclear cells.
Shanghai Zhangjiang Biobank
10 million
It is reported that the biobank is projected to reach a storage capacity of 10 million human-derived samples, such as human tissue, cells, blood, and intestinal microflora.
“All of Us” Biobank
1 million
Blood, urine, saliva, physical measurements, electronic health records, wearable device data.
The International Agency for Research on Cancer (IARC) Biobank (IBB)
562,000
Most of the samples are body fluids, including plasma, serum, urine, and extracted DNA samples
China Kadoorie Biobank
510,000
Blood (plasma, buffy coat), urine, saliva, fecal samples.
UK Biobank
500,000
Blood, urine, saliva, physical measurements, imaging data, genetic data, and health records.
FINNGEN biobanks
500,000
Blood samples, DNA, and health registry data.
Canadian Partnership for Tomorrow’s Health
330,000
Blood, urine, physical measurements, lifestyle and health questionnaires.
Estonian Biobank
200,000
DNA, blood, phenotype data, microbiome samples, RNA, and metabolomics data.
EuroBioBank network
150,000
DNA, RNA, plasma, serum, muscle tissue, fibroblasts, cell lines, and other rare disease biospecimens
Source:Biobanking.com
Market Concentration & Characteristics
The biobanks market has witnessed significant innovation, from traditional sample storage to incorporating advanced data management, analytics tools, and automation. Integration of omics technologies, such as genomics, and increased collaboration globally have further enhanced research capabilities. These developments accelerate biomedical research and contribute to the evolution of personalized medicine.
The biobanks market is also characterized by a high level of mergers and acquisitions (M&A) activity by the leading players. This is due to several factors, including the desire to gain access to new biobank technologies and talent, the need to consolidate in a rapidly growing market, and its usage in research and development.
The market is also subject to increasing regulatory scrutiny. These regulations dictate the responsible collection, storage, and use of biological samples, emphasizing informed consent, privacy protection, and data security. Compliance is crucial for ensuring the reliability of stored samples, facilitating international collaboration, and addressing emerging ethical considerations related to advancements in technologies such as genomics and data analytics.
Product expansion in the biobanks market involves strategic initiatives to introduce new services and offerings. The key players focus on diversifying sample collections, implementing advanced data management systems, providing specialized services, creating collaborative platforms, integrating omics technologies, adopting automation, and establishing global partnerships.
In the biobanks industry, regional expansion involves biobanking entities strategically broadening their activities beyond current geographic boundaries. Hence, key players undertake several business initiatives, such as geographical expansion, partnerships, and collaboration, to gain a regional customer base.
Product & Services Insights
The services segment dominated the market and accounted for the largest revenue share in 2024 and is anticipated to grow at the fastest CAGR during the forecast period. Governments and research organizations are investing heavily in large-scale genomics and biomarker studies, creating sustained demand for high-quality biospecimen collection, processing, and storage. Additionally, advancements in biobanking technologies, such as automated storage systems, digital sample tracking, and cloud-based data integration, are enhancing the efficiency and scalability of biobank operations. Regulatory support and collaborations between academia, industry, and healthcare institutions further accelerate the adoption of biobanking services.
The product segment is anticipated to grow at a significant CAGR during the forecast period. The growth of this segment is primarily driven by the growing need for advanced storage and preservation equipment to support the rising volume and diversity of biological samples used in research and clinical applications. In February 2023, UK Biobank announced that it made a public dataset from 45,000 Magnetic Resonance Imaging (MRI) scans.
Biospecimen Type Insights
Based on biospecimen type, the global biobanks market has been categorized into human tissues, organs, stem cells, and other biospecimen. The human tissues segment captured the largest revenue share of 36.74% in 2024, owing to a large number of biobanks with facilities to store tissues, easy availability of tissue samples, and availability of advanced technology for storage and retrieval of banked tissues. Growing investment in disease-specific R&D is anticipated to foster the demand for diseased tissue samples, such as lymphoma, myeloma, ovarian leukemia, brain, prostate, colorectal carcinoma, breast, and lung tissues for oncology studies.
In the effort to advance the research on COVID-19 and improve its diagnosis and treatment, the stem cells segment is expected to witness the fastest growth during the forecast period. The number of established stem cell biobanks has been increasing rapidly worldwide. Promising applications of stem cells in regenerative medicine, cell therapy, developmental biology, toxicology, and drug development can be attributed to the rapid increase in the number of stem cell banks. Preservation of cellular characteristics, preventing deterioration & contamination, use in basic & translation research, and potential and current use in clinical applications are factors that significantly contributed to the adoption of stem cell banking.
Biobanks Type Insights
Based on biobanks type, the global market is bifurcated into physical/real biobanks and virtual biobanks. The physical/real biobanks segment dominated the market in 2024 and accounted for the largest revenue share of 75.24%. These biobanks have a well-established network, thereby holding a high revenue share. Rapid progress in the fields of bioinformatics analysis and precision medicine can be attributed to this change in the operating strategy of the biobanks. A large collection of tissue samples from pathological labs, clinical trials, and research projects over the years contributes to the largest share of tissue banks in 2024.
The virtual biobanks segment is expected to witness the fastest CAGR over the forecast period. Virtual biobanks have emerged to address the problems related to the accessibility of biospecimen. Tissue Solutions (Scotland) and Human Focused Testing (Little port) are examples of organizations whose core operating activity involves procurement and distribution of samples as per requirement. The potential to fulfill the need for biospecimens and the ability to trace and obtain rare samples improves with virtual biobanking. Also, easy accessibility associated with virtual biobanks contributes to the lucrative growth of the segment.
Application Insights
Based on application, the biobanks industry is categorized into therapeutics, drug discovery & clinical research, clinical diagnostics, and other applications. In 2024, the therapeutics application segment dominated the market with the largest revenue share of 37.63%. This can be attributed to the ever-increasing demand for advanced therapies for treatment of chronic diseases. The exponential increase in the number of COVID-19 cases across the globe has resulted in an increasing need for development of novel viral therapeutics. Various studies are being conducted to accelerate research in this field.
On the other hand, the clinical diagnostics segment is anticipated to witness a significant growth over the forecast period. Comparison of biospecimen obtained from healthy and diseased individuals advances the clinical diagnosis process, especially for cancer. It helps investigate the treatment response of the patient and identify a new tumor in a patient with a history of cancer.
Regional Insights
North America accounted for the second largest revenue share of the biobanks industry in 2024, owing to the advanced healthcare infrastructure, strong government and private sector funding for genomics and personalized medicine, and a well-established regulatory framework supporting biobanking practices. The presence of large-scale initiatives like the NIH-funded “All of Us” research program and extensive academic and commercial research in genomics fuel demand for biobanking services and products. High awareness and adoption of digital and automated storage solutions further accelerate market growth in the region.
U.S. Biobanks Market Trends
In the U.S., biobank industry’s growth is propelled by major government-led initiatives in precision medicine, increasing investments in cancer and rare disease research, and the presence of prominent research institutions and pharmaceutical companies. Programs like the National Cancer Institute’s biorepositories and increased focus on interoperability of health data are pushing for standardized and scalable biobanking solutions. The country also benefits from a mature digital health ecosystem that supports efficient sample and data management.
Europe Biobanks Market Trends
Europe biobanks industry accounted for the largest revenue share of 39.37% in 2024, owing to the continuous investment in the collection, establishment, and processing of large-scale datasets. Furthermore, countries like the UK, Germany, and France are contributing to the regional market growth by investing in biobank solutions. For instance, in June 2023, The Medicines and Healthcare products Regulatory Agency (MHRA) collaborated with Genomics England to launch its genetic biobank.
The UK biobanks market growth is significantly driven by national-scale programs such as the UK Biobank project, which supports broad research initiatives in public health, genomics, and epidemiology. Strong academic-industry collaboration, government support, and integration of biobanking into NHS-backed health research projects contribute to the robust demand for biobanking infrastructure and data analytics tools. Additionally, policy support around open data sharing fosters innovation and multi-institutional collaboration.
The biobanks market in Germany is influenced by initiatives like the German Biobank Node (GBN) and its integration into the Network of University Medicine (NUM), aimed at centralizing and digitizing biobanking resources. Federal funding through agencies like BMBF supports the development of standardization, quality control, and cross-institutional interoperability, while strong pharmaceutical and diagnostics sectors drive sample demand. Advanced hospital networks and academic research institutions also support market expansion.
Asia Pacific Biobanks Market Trends
The Asia Pacific biobanks industry is expected to witness the fastest CAGR over the forecast period. The growth can be attributed to the investment of developing economies like India, China, and Japan. These countries are actively engaged in developing the biobank market by undertaking several business initiatives to strengthen their market position. For instance, in November 2023, AIG Hospital launched its first biobank in India’s southern region. The biobank will collect over one lakh tissue and blood samples for the upcoming decade.
China biobanks market is rapidly expanding, fueled by national efforts to become a global leader in biomedical research, large-scale population genomics projects, and increasing health data digitization. Government-backed initiatives like the China Kadoorie Biobank and rising investment in biotechnology create significant demand for storage systems, sample prep, and high-throughput sequencing tools. Local manufacturing growth and foreign collaborations further stimulate the product and services landscape.
The biobanks market in Japan benefits from a strong emphasis on aging-related and personalized medicine research. Government-funded efforts such as BioBank Japan support large-scale health data collection, particularly for chronic disease research. Technological innovation, combined with Japan’s high standard of healthcare and research integrity, fosters strong demand for integrated biobanking solutions. Additionally, collaborations with global biopharma companies push demand for standardized and automated systems.
MEA Biobanks Market Trends
The Middle East & Africa region shows growing interest in biobanking due to increasing investments in healthcare infrastructure, precision medicine, and population health research. Countries like the UAE and Qatar are developing national biobank programs, while Africa is seeing rising participation in infectious disease and genomics studies. However, challenges like limited standardization and funding disparities remain, although international collaborations are helping to close gaps and drive adoption.
Saudi Arabia’s biobanks market is expanding as part of its Vision 2030 strategy, which includes a strong focus on healthcare digitization and genomics. The launch of national initiatives such as the Saudi Human Genome Program and investments in biotech parks and research universities are fueling the need for advanced biobanking systems. Strong government backing and a push for personalized healthcare solutions support both infrastructure and product market growth.
The biobanks market in Kuwait is expected to develop in tandem with public health and precision medicine initiatives, with support from the Ministry of Health and regional research collaborations. Focused efforts on chronic disease research, especially diabetes and cardiovascular conditions, are driving demand for sample collection and storage infrastructure. However, the market is still at an early stage and is likely to benefit from partnerships with global biobank technology providers.
Heat Map Analysis
The biobanking market is supported by key players such as Thermo Fisher Scientific Inc., Merck KGaA, Qiagen, Stemcell Technologies, and PromoCell GmbH, each offering specialized products and services. Thermo Fisher dominates with a broad portfolio including cryogenic storage, automated sample handling, and data management systems, making it a comprehensive solutions provider with a global footprint. Merck KGaA focuses on cell culture media, cryopreservation reagents, and biobank-compatible consumables, leveraging its strong European presence.
Qiagen is known for its sample preparation kits and automation systems like QIAsymphony and QIAcube, particularly suited for genomic and molecular biobanking. Stemcell Technologies supports regenerative medicine and stem cell biobanking with advanced cell culture tools and reagents, particularly in North America and Europe. PromoCell GmbH, while more niche, contributes through its high-quality human primary cells and cryopreserved samples used in research biobanks across Europe. Together, these players represent the technological and regional diversity driving innovation and adoption in the biobanking product and service landscape.
Key Biobanks Company Insights
Some of the key players operating in the market are adopting various organic & inorganic strategies, such as collaborations with biobanking service providers and technological innovation to advance their product offerings in the biobanking industry.
Key Biobanks Companies:
The following are the leading companies in the biobanks market. These companies collectively hold the largest market share and dictate industry trends.
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Qiagen
- Hamilton Company
- Tecan Trading AG
- Danaher Corporation
- Becton, Dickinson, and Company (BD)
- Biocision, LLC.
- Taylor-Wharton
- Charles River Laboratories
- Lonza
- Stemcell Technologies
- Biovault Family
- Promocell GmbH
- Precision Cellular Storage Ltd. (Virgin Health Bank)
Recent Developments
-
In July 2025, the German Biobank Node (GBN) will become part of the Network of University Medicine (NUM). This integration aligns with the recent approval of NUM’s new funding phase (NUM 3.0) by the Federal Ministry of Education and Research (BMBF) last week.
-
In May 2024, EIT Health introduced a new Biobanks and Health Data Portal designed to enhance collaboration and promote the broader use of biobanks.
-
In December 2023, Charles River Laboratories International, Inc. announced an agreement with CELLphenomics. The CELLphenomics biobank has over 500 in vitro models from around 20 tumor entities. It offers one of the largest complex in vitro models of rare and ultra-rare tumors like thymomas or sarcomas.
-
In October 2023, AstraZeneca research announced unique relationships between rare changes in plasma proteins and genes that could enhance drug discovery with data from more than 50,000 UK Biobank participants.
-
In July 2023, Tecan announced the launch of Phase Separator. It has several applications in biobanking and liquid biopsy and is expected to benefit proteomics, genomics, and across numerous disease areas, from neurodegenerative and oncology diseases to metabolic disorders.
Biobanks Market Report Scope
Report Attribute
Details
Market size value in 2025
USD 86.82 billion
Revenue forecast in 2030
USD 126.69 billion
Growth rate
CAGR of 7.85% from 2025 to 2030
Actual data
2018 - 2024
Forecast period
2025 - 2030
Quantitative units
Revenue in USD million/billion, and CAGR from 2025 to 2030
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Product, biospecimen type, biobanks type, application, region
Regional scope
North America; Europe; Asia Pacific; Latin America; MEA
Country scope
U.S.; Canada; Mexico; Germany; UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait
Key companies profiled
Thermo Fisher Scientific Inc.; Merck KGaA; Qiagen; Hamilton Company; Tecan Trading AG; Danaher Corporation; Becton, Dickinson, and Company (BD); Biocision, LLC.; Taylor-Wharton; Charles River Laboratories; Lonza; Stemcell Technologies; Biovault Family; Promocell GmbH; Precision Cellular Storage Ltd. (Virgin Health Bank)
Customization scope
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
Global Biobanks Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global biobanks market report based on product & service, biospecimen type, biobanks type, application, and region:
-
Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
-
Product
-
Biobanking Equipment
-
Temperature Control Systems
-
Freezers & Refrigerators
-
Cryogenic Storage Systems
-
Thawing Equipment
-
-
Incubators & Centrifuges
-
Alarms & Monitoring Systems
-
Accessories & Other Equipment
-
-
Biobanking Consumables
-
Laboratory Information Management Systems
-
-
Services
-
Biobanking & Repository
-
Lab processing
-
Qualification/ Validation
-
Cold Chain Logistics
-
Other Services
-
-
-
Biospecimen Type Outlook (Revenue, USD Million, 2018 - 2030)
-
Human Tissues
-
Human Organs
-
Stem Cells
-
Adult Stem Cells
-
Embryonic Stem Cells
-
IPS Cells
-
Other Stem Cells
-
-
Other Biospecimens
-
-
Biobanks Type Outlook (Revenue, USD Million, 2018 - 2030)
-
Physical/Real Biobanks
-
Tissue Biobanks
-
Population Based Biobanks
-
Genetic (DNA/RNA)
-
Disease Based Biobanks
-
-
Virtual Biobanks
-
-
Application Type Outlook (Revenue, USD Million, 2018 - 2030)
-
Therapeutics
-
Drug Discovery & Clinical Research
-
Clinical Diagnostics
-
Other Applications
-
-
Regional Outlook (Revenue, USD Million, 2018 - 2030)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
Germany
-
UK
-
France
-
Spain
-
Italy
-
Denmark
-
Sweden
-
Norway
-
-
Asia Pacific
-
China
-
Japan
-
India
-
South Korea
-
Australia
-
-
Latin America
-
Brazil
-
Argentina
-
-
Middle East and Africa (MEA)
-
South Africa
-
Saudi Arabia
-
UAE
-
Kuwait
-
-
Frequently Asked Questions About This Report
b. The global biobank market size was estimated at USD 81.29 billion in 2024 and is expected to reach USD 86.82 billion in 2025.
b. The global biobank market is expected to grow at a compound annual growth rate of 7.85% from 2025 to 2030 to reach USD 126.69 billion by 2030.
b. On the basis of product & services, the services segment dominated the market and accounted for the largest revenue share in 2024 and is anticipated to grow at the fastest CAGR during the forecast period. Governments and research organizations are investing heavily in large-scale genomics and biomarker studies, creating sustained demand for high-quality biospecimen collection, processing, and storage. Additionally, advancements in biobanking technologies—such as automated storage systems, digital sample tracking, and cloud-based data integration—are enhancing the efficiency and scalability of biobank operations.
b. Some key players operating in the biobank market include Thermo Fisher Scientific Inc.; Merck KGaA; QIAGEN; Hamilton Company; Tecan Trading AG; Danaher Corporation; Becton, Dickinson and Company (BD); BioCision, LLC; Taylor-Wharton; Charles River Laboratories; Lonza; STEMCELL Technologies; Biovault Family; PromoCell GmbH; Precision Cellular Storage Ltd. (Virgin Health Bank)
b. Key factors that are driving the biobank market growth are the increasing popularity of fertility preservation services, investment in facility expansion for biobanking, and growing collaborations between biobanks and end-users.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product & Services
1.2.2. Biospecimen Type
1.2.3. Biobanks Type
1.2.4. Application
1.3. Research Methodology
1.4. Information Procurement
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Biobanks Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Continuous increase in COVID-19 cases along with capacity expansion
3.2.1.2. Increased focus on precision medicine and genetic testing
3.2.1.3. Changes in biobanking operations
3.2.1.4. Increase in the number of clinical trials globally
3.2.1.5. Growing industry and research collaborations
3.2.1.6. Technology advancement and automation
3.2.2. Market restraint analysis
3.2.2.1. Disruptions in supply chain management due to COVID-19
3.2.2.2. Challenges in sharing biobanking data & limited access to biospecimens
3.2.2.3. Sustainability challenges for biobanks
3.2.2.4. Other challenges in biobanking specimens for research
3.3. Biobanks Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Biobanks Market: Product & Services Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Product & Services Market Share, 2024 & 2030
4.3. Product
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Biobank Equipment
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.2. Temperature Control Systems
4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.2.2. Freezers & Refrigerators
4.4.1.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.2.3. Cryogenic Storage Systems
4.4.1.2.4. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.2.5. Thawing Equipment
4.4.1.2.6. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.3. Incubators & Centrifuges
4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.4. Alarms & Monitoring Systems
4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.5. Accessories & Other Equipment
4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Biobanking Consumables
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Laboratory Information Management Systems
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Services
4.6. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.6.1. Biobanking & repository
4.6.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.2. Lab processing
4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.3. Qualification/ Validation
4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.4. Cold Chain Logistics
4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.5. Other Services
4.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Biobanks Market: Biospecimen Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Biospecimen Type Market Share, 2024 & 2030
5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.3.1. Human Tissues
5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
5.3.2. Human Organs
5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.3. Stem Cells
5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.3.2. Adult Stem Cells
5.3.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.3.3. Embryonic Stem Cells
5.3.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.3.4. IPS Cells
5.3.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.3.5. Other Stem Cells
5.3.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.4. Other biospecimens
5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Biobanks Market: Biobanks Type Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Biobanks Type Market Share, 2024 & 2030
6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.3.1. Physical/Real biobanks
6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.3.1.2. Tissue Biobanks
6.3.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.1.3. Population based biobanks
6.3.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.1.4. Genetic (DNA/RNA)
6.3.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.1.5. Disease based biobanks
6.3.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.2. Virtual biobanks
6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Biobanks Market: Application Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Application Market Share, 2024 & 2030
7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.3.1. Therapeutics
7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Drug discovery & clinical research
7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.3. Clinical Diagnostics
7.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.4. Other Applications
7.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Biobanks Market: Regional Estimates & Trend Analysis
8.1. Regional Market Dashboard
8.2. Regional Market Share Analysis, 2024 & 2030
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.4. North America
8.4.1. U.S.
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework/ reimbursement structure
8.4.1.3. Competitive scenario
8.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.4.2. Canada
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework/ reimbursement structure
8.4.2.3. Competitive scenario
8.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.4.3. Mexico
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework/ reimbursement structure
8.4.3.3. Competitive scenario
8.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Europe
8.5.1. UK
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework/ reimbursement structure
8.5.1.3. Competitive scenario
8.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. Germany
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework/ reimbursement structure
8.5.2.3. Competitive scenario
8.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. France
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework/ reimbursement structure
8.5.3.3. Competitive scenario
8.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
8.5.4. Italy
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework/ reimbursement structure
8.5.4.3. Competitive scenario
8.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.5.5. Spain
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework/ reimbursement structure
8.5.5.3. Competitive scenario
8.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.5.6. Norway
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework/ reimbursement structure
8.5.6.3. Competitive scenario
8.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.5.7. Sweden
8.5.7.1. Key country dynamics
8.5.7.2. Regulatory framework/ reimbursement structure
8.5.7.3. Competitive scenario
8.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.5.8. Denmark
8.5.8.1. Key country dynamics
8.5.8.2. Regulatory framework/ reimbursement structure
8.5.8.3. Competitive scenario
8.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Japan
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework/ reimbursement structure
8.6.1.3. Competitive scenario
8.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. China
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework/ reimbursement structure
8.6.2.3. Competitive scenario
8.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. India
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework/ reimbursement structure
8.6.3.3. Competitive scenario
8.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. Australia
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework/ reimbursement structure
8.6.4.3. Competitive scenario
8.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. South Korea
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework/ reimbursement structure
8.6.5.3. Competitive scenario
8.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. Thailand
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework/ reimbursement structure
8.6.6.3. Competitive scenario
8.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Latin America
8.7.1. Brazil
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework/ reimbursement structure
8.7.1.3. Competitive scenario
8.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. Argentina
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework/ reimbursement structure
8.7.2.3. Competitive scenario
8.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.8. MEA
8.8.1. South Africa
8.8.1.1. Key country dynamics
8.8.1.2. Regulatory framework/ reimbursement structure
8.8.1.3. Competitive scenario
8.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.8.2. Saudi Arabia
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework/ reimbursement structure
8.8.2.3. Competitive scenario
8.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.8.3. UAE
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework/ reimbursement structure
8.8.3.3. Competitive scenario
8.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.8.4. Kuwait
8.8.4.1. Key country dynamics
8.8.4.2. Regulatory framework/ reimbursement structure
8.8.4.3. Competitive scenario
8.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
9.4.1. Thermo Fisher Scientific Inc.
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Merck KGaA
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Qiagen
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Hamilton Company
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Tecan Trading AG
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Danaher Corporation
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Becton, Dickinson, and Company (BD)
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Biocision, LLC.
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Taylor-Wharton
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Charles River Laboratories
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
9.4.11. Lonza
9.4.11.1. Company overview
9.4.11.2. Financial performance
9.4.11.3. Product benchmarking
9.4.11.4. Strategic initiatives
9.4.12. Stemcell Technologies
9.4.12.1. Company overview
9.4.12.2. Financial performance
9.4.12.3. Product benchmarking
9.4.12.4. Strategic initiatives
9.4.13. Biovault Family
9.4.13.1. Company overview
9.4.13.2. Financial performance
9.4.13.3. Product benchmarking
9.4.13.4. Strategic initiatives
9.4.14. Promocell GmbH
9.4.14.1. Company overview
9.4.14.2. Financial performance
9.4.14.3. Product benchmarking
9.4.14.4. Strategic initiatives
9.4.15. Precision Cellular Storage Ltd. (Virgin Health Bank)
9.4.15.1. Company overview
9.4.15.2. Financial performance
9.4.15.3. Product benchmarking
9.4.15.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America biobanks market, by region, 2018 - 2030 (USD Million)
Table 3 North America biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 4 North America biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 5 North America biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 6 North America biobanks market, by application, 2018 - 2030 (USD Million)
Table 7 U.S. biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 8 U.S. biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 9 U.S. biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 10 U.S. biobanks market, by application, 2018 - 2030 (USD Million)
Table 11 Mexico biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 12 Mexico biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 13 Mexico biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 14 Mexico biobanks market, by application, 2018 - 2030 (USD Million)
Table 15 Canada biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 16 Canada biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 17 Canada biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 18 Canada biobanks market, by application, 2018 - 2030 (USD Million)
Table 19 Europe biobanks market, by region, 2018 - 2030 (USD Million)
Table 20 Europe biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 21 Europe biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 22 Europe biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 23 Europe biobanks market, by application, 2018 - 2030 (USD Million)
Table 24 Germany biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 25 Germany biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 26 Germany biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 27 Germany biobanks market, by application, 2018 - 2030 (USD Million)
Table 28 UK biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 29 UK biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 30 UK biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 31 UK biobanks market, by application, 2018 - 2030 (USD Million)
Table 32 France biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 33 France biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 34 France biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 35 France biobanks market, by application, 2018 - 2030 (USD Million)
Table 36 Italy biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 37 Italy biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 38 Italy biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 39 Italy biobanks market, by application, 2018 - 2030 (USD Million)
Table 40 Spain biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 41 Spain biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 42 Spain biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 43 Spain biobanks market, by application, 2018 - 2030 (USD Million)
Table 44 Denmark biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 45 Denmark biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 46 Denmark biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 47 Denmark biobanks market, by application, 2018 - 2030 (USD Million)
Table 48 Sweden biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 49 Sweden biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 50 Sweden biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 51 Sweden biobanks market, by application, 2018 - 2030 (USD Million)
Table 52 Norway biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 53 Norway biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 54 Norway biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 55 Norway biobanks market, by application, 2018 - 2030 (USD Million)
Table 56 Asia Pacific biobanks market, by region, 2018 - 2030 (USD Million)
Table 57 Asia Pacific biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 58 Asia Pacific biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 59 Asia Pacific biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 60 Asia Pacific biobanks market, by application, 2018 - 2030 (USD Million)
Table 61 China biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 62 China biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 63 China biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 64 China biobanks market, by application, 2018 - 2030 (USD Million)
Table 65 Japan biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 66 Japan biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 67 Japan biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 68 Japan biobanks market, by application, 2018 - 2030 (USD Million)
Table 69 India biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 70 India biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 71 India biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 72 India biobanks market, by application, 2018 - 2030 (USD Million)
Table 73 South Korea biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 74 South Korea biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 75 South Korea biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 76 South Korea biobanks market, by application, 2018 - 2030 (USD Million)
Table 77 Australia biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 78 Australia biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 79 Australia biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 80 Australia biobanks market, by application, 2018 - 2030 (USD Million)
Table 81 Thailand biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 82 Thailand biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 83 Thailand biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 84 Thailand biobanks market, by application, 2018 - 2030 (USD Million)
Table 85 Latin America biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 86 Latin America biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 87 Latin America biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 88 Latin America biobanks market, by application, 2018 - 2030 (USD Million)
Table 89 Brazil biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 90 Brazil biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 91 Brazil biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 92 Brazil biobanks market, by application, 2018 - 2030 (USD Million)
Table 93 Argentina biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 94 Argentina biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 95 Argentina biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 96 Argentina biobanks market, by application, 2018 - 2030 (USD Million)
Table 97 MEA biobanks market, by region, 2018 - 2030 (USD Million)
Table 98 MEA biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 99 MEA biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 100 MEA biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 101 MEA biobanks market, by application, 2018 - 2030 (USD Million)
Table 102 South Africa biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 103 South Africa biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 104 South Africa biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 105 South Africa biobanks market, by application, 2018 - 2030 (USD Million)
Table 106 Saudi Arabia biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia biobanks market, by application, 2018 - 2030 (USD Million)
Table 110 UAE biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 111 UAE biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 112 UAE biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 113 UAE biobanks market, by application, 2018 - 2030 (USD Million)
Table 114 Kuwait biobanks market, by product & services, 2018 - 2030 (USD Million)
Table 115 Kuwait biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
Table 116 Kuwait biobanks market, by biobanks type, 2018 - 2030 (USD Million)
Table 117 Kuwait biobanks market, by application, 2018 - 2030 (USD Million)
List of Tables
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Biobanks market: market outlook
Fig. 9 Biobanks competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Biobanks market driver impact
Fig. 15 Biobanks market restraint impact
Fig. 16 Biobanks market strategic initiatives analysis
Fig. 17 Biobanks market: Product & services movement analysis
Fig. 18 Biobanks market: Product & services outlook and key takeaways
Fig. 19 Product market estimates and forecast, 2018 - 2030
Fig. 20 Biobanking equipment market estimates and forecast, 2018 - 2030
Fig. 21 Temperature control systems estimates and forecast, 2018 - 2030
Fig. 22 Freezers & refrigerators market estimates and forecast, 2018 - 2030
Fig. 23 Cryogenic storage systems market estimates and forecast, 2018 - 2030
Fig. 24 Thawing equipment market estimates and forecast, 2018 - 2030
Fig. 25 Incubators & centrifuges market estimates and forecast, 2018 - 2030
Fig. 26 Alarms & monitoring systems market estimates and forecast, 2018 - 2030
Fig. 27 Accessories & other equipment market estimates and forecast, 2018 - 2030
Fig. 28 Biobanking consumables market estimates and forecast, 2018 - 2030
Fig. 29 Laboratory information management systems market estimates and forecast, 2018 - 2030
Fig. 30 Services market estimates and forecasts, 2018 - 2030
Fig. 31 Biobanking & repository market estimates and forecasts, 2018 - 2030
Fig. 32 Lab processing market estimates and forecasts,2018 - 2030
Fig. 33 Qualification/ Validation market estimates and forecasts,2018 - 2030
Fig. 34 Cold chain logistics market estimates and forecasts, 2018 - 2030
Fig. 35 Other services market estimates and forecasts,2018 - 2030
Fig. 36 Biobanks market: Biospecimen type movement analysis
Fig. 37 Biobanks market: Biospecimen type outlook and key takeaways
Fig. 38 Human tissues market estimates and forecasts, 2018 - 2030
Fig. 39 Human organs market estimates and forecasts,2018 - 2030
Fig. 40 Stem cells market estimates and forecasts, 2018 - 2030
Fig. 41 Adult stem cells market estimates and forecasts,2018 - 2030
Fig. 42 Embryonic stem cells market estimates and forecasts, 2018 - 2030
Fig. 43 IPS cells market estimates and forecasts, 2018 - 2030
Fig. 44 Other stem cells market estimates and forecasts, 2018 - 2030
Fig. 45 Other biospecimens market estimates and forecasts, 2018 - 2030
Fig. 46 Biobanks market: Biobanks type movement analysis
Fig. 47 Biobanks market: Biobanks type outlook and key takeaways
Fig. 48 Physical/Real biobanks market estimates and forecasts, 2018 - 2030
Fig. 49 Tissue biobanks market estimates and forecasts,2018 - 2030
Fig. 50 Population based biobanks market estimates and forecasts, 2018 - 2030
Fig. 51 Genetic (DNA/RNA) market estimates and forecasts,2018 - 2030
Fig. 52 Disease based biobanks market estimates and forecasts, 2018 - 2030
Fig. 53 Virtual biobanks market estimates and forecasts, 2018 - 2030
Fig. 54 Biobanks market: Application movement analysis
Fig. 55 Biobanks market: Application outlook and key takeaways
Fig. 56 Therapeutics market estimates and forecasts, 2018 - 2030
Fig. 57 Drug discovery & clinical research market estimates and forecasts,2018 - 2030
Fig. 58 Clinical diagnostics market estimates and forecasts, 2018 - 2030
Fig. 59 Other applications market estimates and forecasts,2018 - 2030
Fig. 60 Global Biobanks market: Regional movement analysis
Fig. 61 Global Biobanks market: Regional outlook and key takeaways
Fig. 62 North America, by country
Fig. 63 North America
Fig. 64 North America market estimates and forecasts, 2018 - 2030
Fig. 65 U.S. country dynamics
Fig. 66 U.S. market estimates and forecasts, 2018 - 2030
Fig. 67 Canada country dynamics
Fig. 68 Canada market estimates and forecasts, 2018 - 2030
Fig. 69 Mexico country dynamics
Fig. 70 Mexico market estimates and forecasts, 2018 - 2030
Fig. 71 Europe market estimates and forecasts, 2018 - 2030
Fig. 72 UK country dynamics
Fig. 73 UK market estimates and forecasts, 2018 - 2030
Fig. 74 Germany country dynamics
Fig. 75 Germany market estimates and forecasts, 2018 - 2030
Fig. 76 France country dynamics
Fig. 77 France market estimates and forecasts, 2018 - 2030
Fig. 78 Italy country dynamics
Fig. 79 Italy market estimates and forecasts, 2018 - 2030
Fig. 80 Spain country dynamics
Fig. 81 Spain market estimates and forecasts, 2018 - 2030
Fig. 82 Denmark country dynamics
Fig. 83 Denmark market estimates and forecasts, 2018 - 2030
Fig. 84 Sweden country dynamics
Fig. 85 Sweden market estimates and forecasts, 2018 - 2030
Fig. 86 Norway country dynamics
Fig. 87 Norway market estimates and forecasts, 2018 - 2030
Fig. 88 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 89 China country dynamics
Fig. 90 China market estimates and forecasts, 2018 - 2030
Fig. 91 Japan country dynamics
Fig. 92 Japan market estimates and forecasts, 2018 - 2030
Fig. 93 India country dynamics
Fig. 94 India market estimates and forecasts, 2018 - 2030
Fig. 95 Thailand country dynamics
Fig. 96 Thailand market estimates and forecasts, 2018 - 2030
Fig. 97 South Korea country dynamics
Fig. 98 South Korea market estimates and forecasts, 2018 - 2030
Fig. 99 Australia country dynamics
Fig. 100 Australia market estimates and forecasts, 2018 - 2030
Fig. 101 Latin America market estimates and forecasts, 2018 - 2030
Fig. 102 Brazil country dynamics
Fig. 103 Brazil market estimates and forecasts, 2018 - 2030
Fig. 104 Argentina country dynamics
Fig. 105 Argentina market estimates and forecasts, 2018 - 2030
Fig. 106 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 107 South Africa country dynamics
Fig. 108 South Africa market estimates and forecasts, 2018 - 2030
Fig. 109 Saudi Arabia country dynamics
Fig. 110 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 111 UAE country dynamics
Fig. 112 UAE market estimates and forecasts, 2018 - 2030
Fig. 113 Kuwait country dynamics
Fig. 114 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 115 Market position of key market players- Biobanks marketMarket Segmentation
- Biobanks Product & Services Outlook (Revenue in USD Million, 2018 - 2030)
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- Biobanks Biospecimen Type Outlook (Revenue in USD Million; 2018 - 2030)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Biobanks Type Outlook (Revenue in USD Million; 2018 - 2030)
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Biobanks Application Outlook (Revenue in USD Million; 2018 - 2030)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Biobanks Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- North America Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- North America Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- North America Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- U.S.
- U.S. Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- U.S. Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- U.S. Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- U.S. Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- U.S. Biobanks Market, by Product & Services
- Canada
- Canada Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- Canada Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Canada Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Canada Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Canada Biobanks Market, by Product & Services
- Mexico
- Mexico Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- Mexico Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Mexico Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Mexico Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Mexico Biobanks Market, by Product & Services
- North America Biobanks Market, by Product & Services
- Europe
- Europe Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- Europe Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Europe Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Europe Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Germany
- Germany Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- Germany Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Germany Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Germany Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Germany Biobanks Market, by Product & Services
- UK
- UK Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- UK Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- UK Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- UK Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- UK Biobanks Market, by Product & Services
- France
- France Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- France Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- France Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- France Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- France Biobanks Market, by Product & Services
- Italy
- Italy Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- Italy Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Italy Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Italy Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Italy Biobanks Market, by Product & Services
- Spain
- Spain Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- Spain Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Spain Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Spain Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Spain Biobanks Market, by Product & Services
- Denmark
- Denmark Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- Denmark Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Denmark Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Denmark Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Denmark Biobanks Market, by Product & Services
- Sweden
- Sweden Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- Sweden Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Sweden Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Sweden Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Sweden Biobanks Market, by Product & Services
- Norway
- Norway Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- Norway Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Norway Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Norway Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Norway Biobanks Market, by Product & Services
- Europe Biobanks Market, by Product & Services
- Asia Pacific
- Asia Pacific Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- Asia Pacific Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Asia Pacific Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Asia Pacific Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- China
- China Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- China Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- China Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- China Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- China Biobanks Market, by Product & Services
- Japan
- Japan Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- Japan Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Japan Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Japan Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Japan Biobanks Market, by Product & Services
- India
- India Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- India Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- India Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- India Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- India Biobanks Market, by Product & Services
- Thailand
- Thailand Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- Thailand Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Thailand Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Thailand Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Thailand Biobanks Market, by Product & Services
- South Korea
- South Korea Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- South Korea Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- South Korea Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- South Korea Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- South Korea Biobanks Market, by Product & Services
- Australia
- Australia Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- Australia Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Australia Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Australia Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Australia Biobanks Market, by Product & Services
- Asia Pacific Biobanks Market, by Product & Services
- Latin America
- Latin America Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- Latin America Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Latin America Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Latin America Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Brazil
- Brazil Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- Brazil Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Brazil Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Brazil Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Brazil Biobanks Market, by Product & Services
- Argentina
- Argentina Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Argentina Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Product
- Argentina Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Argentina Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Argentina Biobanks Market, by Product & Services
- Latin America Biobanks Market, by Product & Services
- Middle East and Africa
- Middle East and Africa Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- Middle East and Africa Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Middle East and Africa Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Middle East and Africa Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- South Africa
- South Africa Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- South Africa Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- South Africa Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- South Africa Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- South Africa Biobanks Market, by Product & Services
- Saudi Arabia
- Saudi Arabia Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- Saudi Arabia Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Saudi Arabia Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Saudi Arabia Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Saudi Arabia Biobanks Market, by Product & Services
- UAE
- UAE Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- UAE Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- UAE Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- UAE Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- UAE Biobanks Market, by Product & Services
- Kuwait
- Kuwait Biobanks Market, by Product & Services
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking Equipment
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Product
- Kuwait Biobanks Market, by Biospecimen Type
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Kuwait Biobanks Market, by Biobanks Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
- Physical/Real Biobanks
- Kuwait Biobanks Market, by Application
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Kuwait Biobanks Market, by Product & Services
- Middle East and Africa Biobanks Market, by Product & Services
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Regional market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Regional market size and forecast for application segments up to 2030
- Company financial performance
Research Methodology
Grand View Research employs a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. The company utilizes a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. In Addition, a recurring theme prevalent across all our research reports is data triangulation that looks market from three different perspectives. Critical elements of the methodology employed for all our studies include:
Preliminary data mining
Raw market data is obtained and collated on a broad front. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. For a comprehensive understanding of the market, it is essential to understand the complete value chain, and in order to facilitate this; we collect data from raw material suppliers, distributors as well as buyers.
Technical issues and trends are obtained from surveys, technical symposia, and trade journals. Technical data is also gathered from an intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered. As a result, the material developed contains a wide range of original data that is then further cross-validated and authenticated with published sources.
Statistical model
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression, and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, industry experience, and domain expertise.
Econometric models are generally used for short-term forecasting, while technological market models are used for long-term forecasting. These are based on an amalgamation of the technology landscape, regulatory frameworks, economic outlook, and business principles. A bottom-up approach to market estimation is preferred, with key regional markets analyzed as separate entities and integration of data to obtain global estimates. This is critical for a deep understanding of the industry as well as ensuring minimal errors. Some of the parameters considered for forecasting include:
• Market drivers and restraints, along with their current and expected impact
• Raw material scenario and supply v/s price trends
• Regulatory scenario and expected developments
• Current capacity and expected capacity additions up to 2030We assign weights to these parameters and quantify their market impact using weighted average analysis, to derive an expected market growth rate.
Primary validation
This is the final step in estimating and forecasting for our reports. Exhaustive primary interviews are conducted, face to face as well as over the phone to validate our findings and assumptions used to obtain them. Interviewees are approached from leading companies across the value chain including suppliers, technology providers, domain experts, and buyers so as to ensure a holistic and unbiased picture of the market. These interviews are conducted across the globe, with language barriers overcome with the aid of local staff and interpreters. Primary interviews not only help in data validation but also provide critical insights into the market, current business scenario, and future expectations and enhance the quality of our reports. All our estimates and forecast are verified through exhaustive primary research with Key Industry Participants (KIPs) which typically include:
• Market-leading companies
• Raw material suppliers
• Product distributors
• BuyersThe key objectives of primary research are as follows:
• To validate our data in terms of accuracy and acceptability
• To gain an insight in to the current market and future expectationsData Collection Matrix
Perspective
Primary research
Secondary research
Supply-side
- Manufacturers
- Technology distributors and wholesalers
- Company reports and publications
- Government publications
- Independent investigations
- Economic and demographic data
Demand-side
- End-user surveys
- Consumer surveys
- Mystery shopping
- Case studies
- Reference customers
Industry Analysis MatrixQualitative analysis
Quantitative analysis
- Industry landscape and trends
- Market dynamics and key issues
- Technology landscape
- Market opportunities
- Porter’s analysis and PESTEL analysis
- Competitive landscape and component benchmarking
- Policy and regulatory scenario
- Market revenue estimates and forecast up to 2030
- Market revenue estimates and forecasts up to 2030, by technology
- Market revenue estimates and forecasts up to 2030, by application
- Market revenue estimates and forecasts up to 2030, by type
- Market revenue estimates and forecasts up to 2030, by component
- Regional market revenue forecasts, by technology
- Regional market revenue forecasts, by application
- Regional market revenue forecasts, by type
- Regional market revenue forecasts, by component
![pdf icn]()
GET A FREE SAMPLE
![arrow icn]()
This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.
![gvr icn]()
NEED A CUSTOM REPORT?
We offer custom report options, including stand-alone sections and country-level data. Special pricing is available for start-ups and universities.
Request Customization![Certified Icon]()
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
